본문으로 건너뛰기
← 뒤로

Lobectomy or Total Thyroidectomy-Where Is the Pendulum now for Differentiated Thyroid Cancer?

1/5 보강
Surgical oncology clinics of North America 📖 저널 OA 0% 2023: 0/4 OA 2024: 0/2 OA 2025: 0/1 OA 2026: 0/28 OA 2023~2026 2023 Vol.32(2) p. 373-381
Retraction 확인
출처

Fackelmayer OJ, Inabnet WB

📝 환자 설명용 한 줄

Thyroid surgery remains an essential treatment of thyroid cancer.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Fackelmayer OJ, Inabnet WB (2023). Lobectomy or Total Thyroidectomy-Where Is the Pendulum now for Differentiated Thyroid Cancer?. Surgical oncology clinics of North America, 32(2), 373-381. https://doi.org/10.1016/j.soc.2022.10.011
MLA Fackelmayer OJ, et al.. "Lobectomy or Total Thyroidectomy-Where Is the Pendulum now for Differentiated Thyroid Cancer?." Surgical oncology clinics of North America, vol. 32, no. 2, 2023, pp. 373-381.
PMID 36925191 ↗

Abstract

Thyroid surgery remains an essential treatment of thyroid cancer. The historical one-size-fits-all approach to differentiated (papillary and follicular) thyroid carcinoma of total thyroidectomy with central lymph node dissection has been shown to be overtreatment with associated risk of perioperative complications including nerve palsy and hypoparathyroidism. Furthermore, thyroid lobectomy may obviate life-long thyroid hormone replacement. Low-risk thyroid cancers have a low risk of recurrence and those that do recur can be salvaged with reoperation without compromising prognosis. Perioperative risk stratification for recurrence and death greatly influence the need for total thyroidectomy.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반